Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation

Annals of the Rheumatic Diseases

Volumn 62, Issue 3, 2003, Pages 236-241

  Wulffraat, N M ^a   Haas, P J ^a   Frosch, M ^b   de Kleer, I M ^a   Vogl, T ^b   Brinkman, D M C ^c   Quartier, P ^d   Roth, J ^b   Kuis, W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; MYELOID RELATED PROTEIN 14; MYELOID RELATED PROTEIN 8; NAPROXEN; PREDNISONE; PROTEIN; PROTEIN S 100; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; AUTOTRANSPLANTATION; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION; MALE; MONOCYTE; PARAMETER; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; PUBLICATION; QUESTIONNAIRE; RELAPSE; SIDE EFFECT; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; AUTOIMMUNE DISEASES; BLOOD SEDIMENTATION; CALGRANULIN A; CALGRANULIN B; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE COUNT; MALE; PHAGOCYTES; RECURRENCE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0037369377     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.3.236     Document Type: Article

References (31)

1. Guignard F, Mauel J, Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J 1995;309(pt 2):395-401.
2. Newton RA, Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 1998;160:1427-35.
3. Lemarchand P, Vaglio M, Mauel J, Markert M. Translocation of a small cytosolic calcium-binding protein (MRP-8) to plasma membrane correlates with human neutrophil activation. J Biol Chem 1992;267:19379-82.
4. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;27):9496-502.
5. Melkonyan H, Hofmann HA, Nacken W, Sorg C, Klempt M. The gene encoding the myeloid-related protein 14 (MRP14), a calcium-binding protein expressed in granulocytes and monocytes, contains a potent enhancer element in the first intron. J Biol Chem 1998;273:27026-32.
6. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000;43:628-7.
7. Sherry DD. What's new in the diagnosis and treatment of juvenile rheumatoid arthritis. J Pediatr Orthop 2000;20:419-20.
8. Pisetsky DS. Tumor necrosis factor blockers in rheumatoid arthritis. N Engl J Med 2000;342:810-11.
9. Wulffraat NM, Sanders LA, Kuis W. Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2000;2:316-23.
10. Wulffraat NM, van Royen A, Bierings M, Vossen J, Kuis W. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999;353:550-3.
11. Joske DJ, Ma DT, Langlands DR, Owen ET. Autologous bone-marrow transplantation for rheumatoid arthritis. Lancet 1997;350:337-8.
12. Tyndall A, Black C, Finke J, Winkler J, Mertlesmann R, Peter HH, et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997;349:254.
13. Marmont AM, van Lint MT, Gualandi F, Bacigalupo A. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997;6:545-8.
14. Tyndall A, Gratwohl A. Bone marrow transplantation in the treatment of autoimmune diseases. Br J Rheumatol 1997;36:1-3.
15. Brooks PM, Atkinson K, Hamilton JA. Stem cell transplantation in autoimmune disease. J Rheumatol 1995;22:1809-11.
16. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, et al. Peripheral bload stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997;20:631-8.
17. Roth J, Teigelkamp S, Wilke M, Grun L, Tummler B, Sorg C. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992;186:304-14.
18. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9
19. Ruperto N, Ravelli A, Falcini F, Lepore L, De Sanctis R, Zulian F, et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis 1998;57:38-41.
20. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
21. Fuchs HA, Pincus T. Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994;37:470-5.
22. Len C, Ferraz MB, Goldenberg J, Oliveira LM, Araujo PP, Quaresma MR, et al. Pediatric Escola Paulista de Medicina Range of Motion Scale: a reduced joint count scab for general use in juvenile rheumatoid arthritis. J Rheumatol 1999;26:909-13.
23. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996;129:750-4.
24. Grom AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr 1996;129:630-2.
25. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporin. J Pediatr 1996;128:275-8.
26. Quartier P, Prieur AM, Fischer A. Disseminated toxoplasmosis following autologous bone marrow transplantation for systemic onset juvenile chronic arthritis. Lancet 1999;353:1885-6.
27. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, Zwadlo G, et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987;330:80-2.
28. Roth J, Goebeler M, van den BC, Sorg C. Expression of calcium-binding proteins MRP8 and MRP14 is associated with distinct monocytic differentiation pathways in HL-60 cells. Biochem Biophys Res Commun 1993;191:565-70.
29. Roth J, Goebeler M, Wrocklage V, van den BC, Sorg C. Expression of the calcium-binding proteins MRP8 and MRP14 in monocytes is regulated by a calcium-induced suppressor mechanism. Biochem J 1994;301(pt 3):655-60.
30. van Bekkum DW. Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation. Rheumatology (Oxford) 1999;38:757-61.
31. Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993;11:451-6.